Publications<< Back
Brugaletta S, Sabaté M, Martín-Yuste V, Masotti M, Shiratori Y, Alvarez-Contreras L, Cequier A, Iñiguez A, Serra A, Hernández-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Gomez-Lara J, Backx B, Serruys PW
Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial.
Int. J. Cardiol.. 2013 Oct;168(3):2632-6, PMID: 23578890
Few data are available about safety of second generation drug eluting stents in an all-comer ST elevation myocardial infarction (STEMI) population. We sought to investigate the predictors and clinical implications of 1-year stent thrombosis (ST) in patients with STEMI, included in the EXAMINATION trial.
CARDIAC & CARDIOVASCULAR SYSTEMS
An initiative of
